SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-16-005364
Filing Date
2016-08-29
Accepted
2016-08-29 13:57:31
Documents
37
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mjpharma10q063016.htm 10-Q 379409
2 EX-31 ex31.htm EX-31 27851
3 EX-32 ex32.htm EX-32 9976
  Complete submission text file 0001185185-16-005364.txt   1342826

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT mela-20160630.xml EX-101.INS 115131
5 XBRL TAXONOMY EXTENSION SCHEMA mela-20160630.xsd EX-101.SCH 16655
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mela-20160630_cal.xml EX-101.CAL 17399
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mela-20160630_def.xml EX-101.DEF 82817
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mela-20160630_lab.xml EX-101.LAB 101582
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mela-20160630_pre.xml EX-101.PRE 86182
Mailing Address 7524 GLENTURRET CIRCLE C/O UREN ENTERPRISES, LLC THE COLONY TX 75056
Business Address 7524 GLENTURRET CIRCLE C/O UREN ENTERPRISES, LLC THE COLONY TX 75056 214-505-3839
MJ Pharmaceuticals Inc. (Filer) CIK: 0001502629 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54811 | Film No.: 161857218
SIC: 7389 Services-Business Services, NEC